Saturday, November 14, 2009
2009 Yi & St Louis Ovarian Cancer Montage at OneTrueMedia.com
Updated photos including Montage of 2008 Special Ovarian Cancer Womens' Montage
partial view: Response - Response to Robert G. Resta Commentary (Unprepared, Understaffed, and Unplanned: Thoughts on the Practical Implications of Di
Response to Robert G. Resta Commentary (Unprepared, Understaffed, and Unplanned: Thoughts on the Practical Implications of Discovering New Breast and Ovarian Cancer Causing Genes
Tuesday, November 10, 2009
Monday, November 09, 2009
Current state of biomarker development for clinical application in epithelial ovarian cancer.
Gynecol Oncol. 2009 Oct 29
Current state of biomarker development for clinical application in epithelial ovarian cancer.
Moore RG, Maclaughlan S, Bast RC Jr.
Program in Women's Oncology, Department of Obstetrics and Gynecology, Women and Infants' Hospital, Alpert Medical School, Brown University, Providence, RI, USA.
Each year in the United States over 15,000 women die of epithelial ovarian cancer (EOC) and 22,000 are diagnosed with the disease. The incidence of ovarian cancer has remained stable over the past decade however, survival rates have improved steadily. Increases in survival rates can be attributed to the advances in surgical management, development of effective cytotoxic drugs and the route of administration of chemotherapy. Ovarian cancer survival rates could also be improved through screening and early detection. Disappointingly, effective screening methods have not been established and continue to be elusive. Historically the goal of a screening test was to achieve a positive predictive value (PPV) greater than 10% in order be considered cost effective and have an acceptable risk for the population being screened. Despite the inability of currently available screening algorithms to achieve the desired PPV there may be an advantage in producing a stage migration to lower stages at the time of diagnoses, thereby resulting in improved survival. Equally important recent studies have demonstrated that women who have their initial surgery performed by gynecologic oncologists, and women who have their surgeries at centers experienced in the treatment of ovarian cancer have higher survival rates. For these reasons it is essential that all women at high risk for ovarian cancer receive their initial care by gynecologic oncologists and at centers with multidisciplinary teams experienced in the optimal care of ovarian cancer patients. With this in mind, methods that facilitate the accurate triage of women who will ultimately be diagnosed with ovarian cancer could play a significant role in improving survival rates for these patients. This review article will examine the current state of biomarker use in ovarian cancer screening, risk assessment and for monitoring ovarian cancer patients.
Qualitative exploration of healthcare relationships following delayed diagnosis of ovarian cancer and subsequent participation in supportive-expressiv
Qualitative exploration of healthcare relationships following delayed diagnosis of ovarian cancer and subsequent participation in supportive-expressive group therapy
CancerView.ca - search results - NIL
Canadian Partnership Against Cancer and affiliate:
Search Results:
SAGE
Target Population -
Age: Adult
Continuum Of Care: Treatment
Type of Cancer: Gynecology
No results found to display
Body mass index as a prognostic factor in epithelial ovarian cancer and correlation with clinico-pathological factors
Conclusion. Overweight and obese patients did not have worse survival than normal weight and underweight patients. The prognostic impact of BMI on survival was only noted for underweight patients with serous tumors.
QUOTE chemo: A patient-centred instrument to measure quality of communication preceding chemotherapy treatment through the patient’s eyes
QUOTE: Odd how the p in patients' is in small caps ??
Sunday, November 08, 2009
Saturday, November 07, 2009
Friday, November 06, 2009
Treatment decision making and its discontents
Soc Work Health Care. 2009 Aug-Sep;48(6):614-34.
Treatment decision making and its discontents.
Sinding C, Wiernikowski J.
Department of Health, Aging, and Society, and School of Social Work, McMaster University, Hamilton, Ontario, Canada. sinding@mcmaster.ca
Patient participation in treatment decision making is held as a virtue in clinical contexts, and has much to recommend it. Yet important questions have been raised about the assumptions underlying models of patient participation. Debates have arisen about the significance of medically defined risks and outcomes of treatment; the adequacy and relevance across social groups of the concept of autonomy; and the emphasis on the professional-patient dyad. This article contributes to the debate about treatment decision making with reference to a study focused on older women with cancer. Interviews with patients and cancer care professionals highlighted the salience to patients' treatment choices of experiential knowledge, social roles and responsibilities, and the health policy context. It appears that prevailing models of decision making may obscure patients' more typical decision processes as well as the social determinants of those choices.
The Contents and Readability of Informed Consent Forms for Oncology Clinical Trials
CONCLUSIONS:: ICF had acceptable readability and provided a realistic overview of the benefits and risks of clinical trials, but the potential for hospitalization or fatality was underreported.
Thursday, November 05, 2009
Update: H1N1 and Cancer
A miracle. Our ovarian cancer friend is now in the hospital and receiving the care that she feels she needs and which she deserves. A good news story!
Wednesday, November 04, 2009
Update - from Nov 3rd - Letter to the Editor H1N1 and Cancer (ovarian cancer woman in need)
Editor's Comment: I received this response and have forwarded the information on to my ovarian cancer friend. It was sent onwards (obviously). One small step and although only the friend herself will know if this will be helpful, it is one small step.
Sandi
Dear Ms. Pnaiuskas, can you forward to her the information that I sent you yesterday? She can also contact me directly.
Thanks,
BC Cancer Agency WebQueries
604-675-8005 604-675-8009
1-888-675-8000, local 8005
* 675 West 10th AvenueVancouver, BC V5Z 1L3
Tuesday, November 03, 2009
Sunday, November 01, 2009
H1N1 and Cancer - update
Letter to the Editor;
With the focus of attention on H1N1 are we allowing care for those desparately ill to go to the bottom of today's priority list? It would seem so. I have a friend in need. The cancer is killing both of us. The cancer is killing my friend because of the disease. It is killing me because I am sitting here watching and listening to this friend who needs help but cannot access palliative care assistance. It seems that this patient has tried to access help without success. I believe there must be a healthcare provider somewhere in this province, who can exercise some form of a miracle and connect the dots. Out of privacy concerns I will not publicly provide this patient's personal information but what I do need is someone in the Vancouver area who has the authority, ability and willingness to help this patient. As a cancer survivour and friend, the best I can do is place a call for action. As a healthcare provider, you have the means to make it work. I will connect you. Please help because we need to and we must. Sandi Pniauskas October 30, 2009 http://ovariancancerandus.blogspot.com http://ovariancancerdebate.blogspot.com/ November 1st, 2009 update: This letter was circulated through
media outlets, Twitter, Facebook, listservs, professional organizations etc. With the exception
of Charles Adler (media broadcaster) and 2 cancer survivours it fell on deaf ears.
Initial evaluation and referral guidelines for management of pelvic/ovarian masses - Canada
"Patients deemed to have a high risk of an underlying malignancy should be reviewed in consultation with a gynaecologic oncologist for assessment and optimal surgical management."
Who are the providers of gynaecologic cancer surgical care in Ontario?
Laparoscopic peritoneal entry preferences among Canadian gynaecologists
Abstract: the response rate to the survey was 45.6%
"CONCLUSIONS: Our survey had a significant response rate and was able to delineate current laparoscopic entry practice patterns of gynaecologists, which were consistent across Canada. Despite 72.9% of respondents reporting familiarity with the recent SOGC clinical practice guideline, it appears that clinical practice does not necessarily coincide with current recommendations. These variances in gynaecological practice emphasize the need for further educational initiatives to ensure that the evidence from research is used to make clinical practice safer."
Subscribe to:
Posts
(
Atom
)
